EBRT with or without STAD showed similar 15-year PCSS and OS rates in IRPC patients, with high PSA failure rates observed. Multivariate analysis indicated greater side effects in the STAD group ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of ...

Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk prostate cancer treated with external-beam radiation therapy (EBRT), ...

Tracking breathing-related prostate movement enables more precise delivery of radiation, study finds. BOSTON—Real-time positional tracking of the prostate could improve external beam radiation ...

To our knowledge, this is the greatest survival benefit, based upon hazard ratio, ever seen in a prostate cancer,” said study presenter Stephen J. Freedland, MD.

The proportion of men with high-risk localized prostate cancer undergoing radical prostatectomy (RP) increased dramatically from 2004 to 2013 such that by the end of the study period, RP and external ...

Risk factors like Gleason score, cancer stage, PSA levels, and genetic markers guide prostate cancer treatment decisions. Treatment options include active surveillance, surgery, radiation, hormone ...

Over a median follow-up of about 50 months, men randomized to CAN-2409 plus prodrug valacyclovir had a 30% reduction in the risk for disease recurrence or death versus placebo plus valacyclovir (HR ...